Disease-related indication |
Suitable donor available |
Karnofsky performance status ≥70 for a myeloablative HCT or ≥50 for a nonmyeloablative HCT |
Renal function:
|
Cardiac reserve:
|
Pulmonary function:
|
Liver function:
|
Adequate psychosocial and financial support |
While no specific age cutoff is universally used, many centers limit myeloablative allo-HCT to patients <55 years and reduced intensity allo-HCT to patients <75 years |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟